The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Jul 28, 2026
Summers Value Fund delivered its best quarter since inception with a 41.7% net return in Q2 2026, driven by concentrated stock picking in small-cap healthcare and biotechnology. The Fund capitalized on a favorable environment where decades of small-cap underperformance and healthcare sector regulatory overhang created attractive entry points at steep discounts. Key contributors included Liquidia, whose Yutrepia launch continues exceeding expectations with pending favorable litigation resolution, Electromed which beat expectations on revenue and net income, and Avanos Medical which was acquired for a 106% total gain. The portfolio is weighted over 50% toward pharmaceutical and biotechnology companies, with significant exposure to royalty business models favored for their high margins and strong cash flow. The manager exited Embecta after underestimating customer concentration risk and business model fragility. With approximately 13% cash, the Fund continues identifying under-the-radar special situations despite a more balanced opportunity set. The manager's family liquid net worth remains fully invested alongside partners.
The Fund pursues concentrated, special situation investments in small-cap healthcare and biotechnology companies trading at steep discounts, with a particular focus on royalty business models that offer high margins, asset-light structures, and strong cash flow generation, capitalizing on idiosyncratic catalysts including M&A, new product launches, and litigation resolutions.
While the environment today is more balanced for sourcing new ideas compared to a year ago, the manager continues to identify and evaluate under-the-radar special situations that fit the investment framework. The manager expects continued strong performance from Liquidia's Yutrepia launch and anticipates favorable litigation resolution. Further appreciation is expected for Consensus Cloud Solutions if management continues to drive higher-than-expected revenue and profits.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Summers Value Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.